Phathom Pharmaceuticals I... (PHAT)

5.58

0.37 (7.10%)

At close: Mar 04, 2025, 3:59 PM

5.63

0.81%

After-hours: Mar 04, 2025, 06:54 PM EST

Phathom Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-201.59M	-197.72M	-143.88M	-129.07M	-255.13M	-1.29M
Depreciation & Amortization	575K	620K	521K	323K	8K	n/a
Stock-Based Compensation	45.02M	24.13M	16.81M	5.84M	406K	n/a
Other Working Capital	-8.97M	-3.24M	-17.68M	27.71M	-11.79M	-10K
Other Non-Cash Items	32.06M	21M	5.41M	1.59M	131.46M	50K
Deferred Income Tax	n/a	n/a	n/a	-95K	96.27M	n/a
Change in Working Capital	-13.64M	5.44M	-27.48M	51.72M	-9.52M	215K
Operating Cash Flow	-137.58M	-146.53M	-148.62M	-69.69M	-36.51M	-1.02M
Capital Expenditures	-1.63M	-1.04M	-328K	-1.04M	-25.25M	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-1.18M	-330K	-1.19M	-25.12M	n/a
Investing Cash Flow	-1.63M	-1.04M	-328K	-1.04M	-25.25M	n/a
Debt Repayment	39.32M	n/a	42.76M	25M	24.85M	1.9M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	172.8M	95.45M	1.94M	629K	279.8M	2K
Financial Cash Flow	367.58M	120.04M	44.71M	114.46M	304.65M	1.9M
Net Cash Flow	228.37M	-27.53M	-104.24M	43.73M	242.89M	879K
Free Cash Flow	-139.21M	-147.57M	-148.94M	-70.73M	-61.76M	-1.02M